EUVIMEDEUVIMED entdecken
Open Access

Blood-Based Analysis of Different Tau Variants in Patients With Multiple Traumatic Injuries

Rebecca Halbgebauer, Fernando Gonzalez-Ortiz, Benjamin Mayer, Claudius Berger, Christian Bergmann, Helen Rinderknecht, Eberhard Barth, Lisa Wohlgemuth, Marco Mannes, Markus Otto, Hayrettin Tumani, Borna Relja und 5 weitere

JAMA Network Open · 10.02.2026 · 9 (2) · e2558573

DOI: 10.1001/jamanetworkopen.2025.58573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 10.02.2026. Verfasst von Rebecca Halbgebauer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical and Experimental Trauma Immunology, Ulm University Medical Center, Ulm, Germany. Hauptthemen laut MEDLINE: tau Proteins, Multiple Trauma, Brain Injuries, Traumatic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance With blood-based phosphorylated tau biomarkers soon to be used for diagnosis of Alzheimer disease, analyzing tau levels in other conditions could enhance biomarker interpretability. Moreover, mechanisms of tau release into circulation remain unclear.

Objective

To evaluate concentrations of phosphorylated and nonphosphorylated tau variants in the blood of patients with multiple traumatic injuries on days 0, 1, 5, and 10 and investigate biological processes driving tau release. Design, Setting, and Participants This multiple-trauma cohort (injury severity score, ≥18) included 45 severely injured patients with (n = 27) and without (n = 18) moderate-to-severe traumatic brain injury on emergency computed tomographic imaging. Controls consisted of 24 healthy volunteers. Participants were recruited from December 1, 2013, to October 31, 2022. Blood samples were analyzed for brain-derived tau (BD-tau), total tau (t-tau), and phosphorylated tau 217 (p-tau217) and 231 (p-tau231) levels. Associations among tau concentrations, clinical data, and outcome (eg, Glasgow Coma Scale [GCS] score) were assessed. Data were analyzed from March 1, 2023, to September 30, 2024. Exposures Serum BD-tau, t-tau, p-tau217, and p-tau231 levels.

Results

A total of 214 serum samples were analyzed. Median age of the 45 patients was 48 (IQR, 33-60) years (35 [77.8%] male); median age of the 24 controls, 43 (IQR, 28-50) years (16 [66.7%] male). Median serum levels of tau variants were increased in patients with multiple traumatic injuries at day 0 compared with controls (t-tau: 43 [IQR, 21-95] vs 3 [IQR, 3-5] pg/mL; BD-tau: 78 [IQR, 30-343] vs 2 [IQR, 2-3] pg/mL; p-tau231: 61 [IQR, 21-79] vs 2 [IQR, 1-3] pg/mL; all, P < .001). Only median BD-tau levels remained elevated until day 10 (day 1, 25 [IQR, 14-69] pg/mL; day 5, 9 [IQR, 4-15] pg/mL; day 10, 8 [IQR, 4-18] pg/mL). Median tau levels at admission were higher in patients with lower GCS scores (BD-tau: 107 [ IQR, 59-838] vs 33 [IQR, 24-78] pg/mL [ P = .01]; p-tau231: 76 [IQR, 36-114] vs 28 [IQR, 9–63] pg/mL [ P = .02]). Elevated median tau levels were also observed in patients with hemorrhagic shock vs those without shock (eg, BD-tau on day 0: 113 [IQR, 78-378] vs 31 [IQR, 24-61] pg/mL; P = .002) and in nonsurvivors vs survivors with uncomplicated courses (eg, BD-tau on day 1: 92 [IQR, 22-527] vs 16 [IQR, 7-23] pg/mL; P = .009). Conclusions and Relevance In this exploratory study among a cohort of patients with multiple traumatic injuries, levels of tau variants reflected both direct and indirect neurological injury, with BD-tau showing the most persistent elevation in the acute phase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsMultiple TraumaBrain Injuries, TraumaticHumansMaleFemaleAdultMiddle AgedBiomarkersPhosphorylationGlasgow Coma ScaleCase-Control StudiesCohort StudiesInjury Severity Score

Substanzen

tau ProteinsBiomarkers

Autor:innen und Institutionen

  • Institute of Clinical and Experimental Trauma Immunology, Ulm University Medical Center, Ulm, Germany.
  • Department of Psychiatry and Neurochemistry, University of Gothenburg, Mölndal, Sweden.
  • Institute for Epidemiology and Medical Biometry, Ulm University, Ulm, Germany.
  • Translational and Experimental Trauma Research, Department of Trauma, Hand, and Reconstructive Surgery, Ulm University Medical Center, Ulm, Germany.
  • Department of Anesthesiology, Ulm University Medical Center, Ulm, Germany.
  • Department of Neurology, University Hospital Halle, Halle (Saale), Germany.

Zitieren

APA

Halbgebauer, R., Gonzalez-Ortiz, F., Mayer, B., Berger, C., Bergmann, C., Rinderknecht, H., Barth, E., Wohlgemuth, L., Mannes, M., Otto, M., Tumani, H., Relja, B., Gebhard, F., Huber-Lang, M., Zetterberg, H., Halbgebauer, S., & Blennow, K. (2026). Blood-Based Analysis of Different Tau Variants in Patients With Multiple Traumatic Injuries. JAMA Network Open, 9(2), e2558573. https://doi.org/10.1001/jamanetworkopen.2025.58573

Vancouver

Halbgebauer R, Gonzalez-Ortiz F, Mayer B, Berger C, Bergmann C, Rinderknecht H, et al. Blood-Based Analysis of Different Tau Variants in Patients With Multiple Traumatic Injuries. JAMA Network Open. 2026;9(2):e2558573. doi:10.1001/jamanetworkopen.2025.58573

BibTeX
@article{Halbgebauer2026,
  author = {Halbgebauer, Rebecca and Gonzalez-Ortiz, Fernando and Mayer, Benjamin and Berger, Claudius and Bergmann, Christian and Rinderknecht, Helen and Barth, Eberhard and Wohlgemuth, Lisa and Mannes, Marco and Otto, Markus and Tumani, Hayrettin and Relja, Borna and Gebhard, Florian and Huber-Lang, Markus and Zetterberg, Henrik and Halbgebauer, Steffen and Blennow, Kaj},
  title = {Blood-Based Analysis of Different Tau Variants in Patients With Multiple Traumatic Injuries},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {e2558573},
  doi = {10.1001/jamanetworkopen.2025.58573}
}
Kostenlos starten →